COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 190 filers reported holding COHERUS BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78 | -14.3% | 20,914 | -1.5% | 0.00% | -25.0% |
| Q2 2023 | $91 | -37.7% | 21,243 | -0.6% | 0.00% | -33.3% |
| Q1 2023 | $146 | -14.1% | 21,365 | -0.3% | 0.01% | -14.3% |
| Q4 2022 | $170 | -99.9% | 21,440 | -16.9% | 0.01% | -30.0% |
| Q3 2022 | $248,000 | +5.1% | 25,793 | -20.8% | 0.01% | +42.9% |
| Q2 2022 | $236,000 | -43.8% | 32,553 | +0.2% | 0.01% | -30.0% |
| Q1 2022 | $420,000 | -29.4% | 32,498 | -12.9% | 0.01% | -16.7% |
| Q4 2021 | $595,000 | -0.3% | 37,307 | +0.5% | 0.01% | -7.7% |
| Q3 2021 | $597,000 | +11.4% | 37,128 | -4.1% | 0.01% | +30.0% |
| Q2 2021 | $536,000 | +0.2% | 38,728 | +5.7% | 0.01% | -9.1% |
| Q1 2021 | $535,000 | +73.1% | 36,628 | +106.1% | 0.01% | +83.3% |
| Q4 2020 | $309,000 | – | 17,769 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |